author-photo

Raelene Hurley

6

Papers

89

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Abstract 3126: H3B6527, a selective and potent FGFR4 inhibitor for FGF19-driven hepatocellular carcinoma

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Combination of PIM and JAK2 inhibitors synergistically suppresses cell proliferation and overcomes drug resistance of myeloproliferative neoplasms

2014 Oncotarget
Show All
- Source
- Cite
- Save
Citations (23)
Abstract 2435: Anticipating clinical resistance to SAR302503, a JAK2 inhibitor in clinical development for the treatment of myelofibrosis.

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Exploring potential clinical resistance to SAR302503, a selective JAK2 inhibitor in clinical development for the treatment of myelofibrosis

2013
Show All
- Source
- Cite
- Save
Citations (0)